| Health / Medical Topics |
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, or PLCO Trial, is a large-scale study to determine if certain tests will reduce the number of deaths from these cancers. Sponsored by the National Cancer Institute (NCI), the study will involve 148,000 men and women ages 55 through 74 at medical facilities in 9 geographic areas across the United States. (Cancer Facts Screening: Questions and Answers About the PLCO Cancer Screening Trial) (NCI Thesaurus)
YOU MAY ALSO LIKE
A blood test that measures the level of prostate-specific antigen (PSA), a substance produced by the prostate and some other tissues in…
A protein made by the prostate gland and found in the blood. Prostate-specific antigen blood levels may be higher than normal in…
A rare malignant neoplasm arising from specialized prostatic stroma. It is characterized by the presence of stromal overgrowth and hypercellularity, increased…
A neoplastic lesion that arises from the prostate gland stroma. Morphologic characteristics include hypercellular stroma with scattered atypical cells, prominent overgrowth…
An invasive prostate carcinoma characterized by the presence of squamous differentiation of the malignant cellular infiltrate. There is no evidence of…
The rate of change in the prostate specific antigen (PSA) level over time. PSA is a protein produced by the cells of…
